> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Cenestin Not Withdrawn Over Safety/Effectiveness: FDA
- URL: https://www.fdaweb.com/cenestin-not-withdrawn-over-safety-effectiveness-fda/
- Published: 2017-08-31T12:00:00.000Z
- Updated: 2026-09-14T22:45:42.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139524

*Federal Register* notice: FDA has determined that Teva’s Cenestin (estrogens, conjugated synthetic A) tablets, 0.3 milligrams (mg), 0.45 mg, 0.625 mg, 0.9 mg, and 1.25 mg, were not withdrawn from sale for reasons of safety or effectiveness. The determination allows the agency to approve ANDAs for these products, if all other legal and regulatory requirements are met. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-08-30/pdf/2017-18376.pdf?ref=fdaweb.com).